mTOR and β-catenin are reported to be the two major effectors of Akt, and we found that UBE2T-mediated pyrimidine metabolism stimulation via Akt/β-catenin but not Akt/mTOR signaling pathway activation in HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.